Diabetic kidney diseases revisited: A new perspective for a new era

Haiyan Fu, Silvia Liu, Sheldon I. Bastacky, Xiaojie Wang, Xiao Jun Tian, Dong Zhou

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Background: Globally, diabetic kidney disease (DKD) is the leading cause of end-stage renal disease. As the most common microvascular complication of diabetes, DKD is a thorny, clinical problem in terms of its diagnosis and management. Intensive glucose control in DKD could slow down but not significantly halt disease progression. Revisiting the tremendous advances that have occurred in the field would enhance recognition of DKD pathogenesis as well as improve our understanding of translational science in DKD in this new era. Scope of review: In this review, we summarize advances in the understanding of the local microenvironmental changes in diabetic kidneys and discuss the involvement of genetic and epigenetic factors in the pathogenesis of DKD. We also review DKD prevalence changes and analyze the challenges in optimizing the diagnostic approaches and management strategies for DKD in the clinic. As we enter the era of ‘big data’, we also explore the possibility of linking systems biology with translational medicine in DKD in the current healthcare system. Major conclusion: Newer understanding of the structural changes of diabetic kidneys and mechanisms of DKD pathogenesis, as well as emergent research technologies will shed light on new methods of dealing with the existing clinical challenges of DKD.

Original languageEnglish (US)
Pages (from-to)250-263
Number of pages14
JournalMolecular Metabolism
Volume30
DOIs
StatePublished - Dec 2019
Externally publishedYes

Fingerprint

Diabetic Nephropathies
Kidney
Translational Medical Research
Systems Biology
Diabetes Complications
Epigenomics
Chronic Kidney Failure
Disease Progression
Technology
Delivery of Health Care
Glucose

Keywords

  • Diabetic kidney disease
  • Epigenetics
  • Genetics
  • Metabolic memory
  • Systems biology

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Diabetic kidney diseases revisited : A new perspective for a new era. / Fu, Haiyan; Liu, Silvia; Bastacky, Sheldon I.; Wang, Xiaojie; Tian, Xiao Jun; Zhou, Dong.

In: Molecular Metabolism, Vol. 30, 12.2019, p. 250-263.

Research output: Contribution to journalReview article

Fu, Haiyan ; Liu, Silvia ; Bastacky, Sheldon I. ; Wang, Xiaojie ; Tian, Xiao Jun ; Zhou, Dong. / Diabetic kidney diseases revisited : A new perspective for a new era. In: Molecular Metabolism. 2019 ; Vol. 30. pp. 250-263.
@article{f8c3ca09abdb496e93621c36ff26c016,
title = "Diabetic kidney diseases revisited: A new perspective for a new era",
abstract = "Background: Globally, diabetic kidney disease (DKD) is the leading cause of end-stage renal disease. As the most common microvascular complication of diabetes, DKD is a thorny, clinical problem in terms of its diagnosis and management. Intensive glucose control in DKD could slow down but not significantly halt disease progression. Revisiting the tremendous advances that have occurred in the field would enhance recognition of DKD pathogenesis as well as improve our understanding of translational science in DKD in this new era. Scope of review: In this review, we summarize advances in the understanding of the local microenvironmental changes in diabetic kidneys and discuss the involvement of genetic and epigenetic factors in the pathogenesis of DKD. We also review DKD prevalence changes and analyze the challenges in optimizing the diagnostic approaches and management strategies for DKD in the clinic. As we enter the era of ‘big data’, we also explore the possibility of linking systems biology with translational medicine in DKD in the current healthcare system. Major conclusion: Newer understanding of the structural changes of diabetic kidneys and mechanisms of DKD pathogenesis, as well as emergent research technologies will shed light on new methods of dealing with the existing clinical challenges of DKD.",
keywords = "Diabetic kidney disease, Epigenetics, Genetics, Metabolic memory, Systems biology",
author = "Haiyan Fu and Silvia Liu and Bastacky, {Sheldon I.} and Xiaojie Wang and Tian, {Xiao Jun} and Dong Zhou",
year = "2019",
month = "12",
doi = "10.1016/j.molmet.2019.10.005",
language = "English (US)",
volume = "30",
pages = "250--263",
journal = "Molecular Metabolism",
issn = "2212-8778",
publisher = "Elsevier GmbH",

}

TY - JOUR

T1 - Diabetic kidney diseases revisited

T2 - A new perspective for a new era

AU - Fu, Haiyan

AU - Liu, Silvia

AU - Bastacky, Sheldon I.

AU - Wang, Xiaojie

AU - Tian, Xiao Jun

AU - Zhou, Dong

PY - 2019/12

Y1 - 2019/12

N2 - Background: Globally, diabetic kidney disease (DKD) is the leading cause of end-stage renal disease. As the most common microvascular complication of diabetes, DKD is a thorny, clinical problem in terms of its diagnosis and management. Intensive glucose control in DKD could slow down but not significantly halt disease progression. Revisiting the tremendous advances that have occurred in the field would enhance recognition of DKD pathogenesis as well as improve our understanding of translational science in DKD in this new era. Scope of review: In this review, we summarize advances in the understanding of the local microenvironmental changes in diabetic kidneys and discuss the involvement of genetic and epigenetic factors in the pathogenesis of DKD. We also review DKD prevalence changes and analyze the challenges in optimizing the diagnostic approaches and management strategies for DKD in the clinic. As we enter the era of ‘big data’, we also explore the possibility of linking systems biology with translational medicine in DKD in the current healthcare system. Major conclusion: Newer understanding of the structural changes of diabetic kidneys and mechanisms of DKD pathogenesis, as well as emergent research technologies will shed light on new methods of dealing with the existing clinical challenges of DKD.

AB - Background: Globally, diabetic kidney disease (DKD) is the leading cause of end-stage renal disease. As the most common microvascular complication of diabetes, DKD is a thorny, clinical problem in terms of its diagnosis and management. Intensive glucose control in DKD could slow down but not significantly halt disease progression. Revisiting the tremendous advances that have occurred in the field would enhance recognition of DKD pathogenesis as well as improve our understanding of translational science in DKD in this new era. Scope of review: In this review, we summarize advances in the understanding of the local microenvironmental changes in diabetic kidneys and discuss the involvement of genetic and epigenetic factors in the pathogenesis of DKD. We also review DKD prevalence changes and analyze the challenges in optimizing the diagnostic approaches and management strategies for DKD in the clinic. As we enter the era of ‘big data’, we also explore the possibility of linking systems biology with translational medicine in DKD in the current healthcare system. Major conclusion: Newer understanding of the structural changes of diabetic kidneys and mechanisms of DKD pathogenesis, as well as emergent research technologies will shed light on new methods of dealing with the existing clinical challenges of DKD.

KW - Diabetic kidney disease

KW - Epigenetics

KW - Genetics

KW - Metabolic memory

KW - Systems biology

UR - http://www.scopus.com/inward/record.url?scp=85074212316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074212316&partnerID=8YFLogxK

U2 - 10.1016/j.molmet.2019.10.005

DO - 10.1016/j.molmet.2019.10.005

M3 - Review article

AN - SCOPUS:85074212316

VL - 30

SP - 250

EP - 263

JO - Molecular Metabolism

JF - Molecular Metabolism

SN - 2212-8778

ER -